Literature DB >> 14737755

Evidence of range bias in contingent valuation payment scales.

David K Whynes1, Jane L Wolstenholme, Emma Frew.   

Abstract

The payment scale format has been widely used in willingness-to-pay studies in health care. Concerns have been expressed that the format is, in theory, prone to range bias, although this proposition has not been tested directly. We report the findings of a contingent valuation questionnaire study of colorectal cancer screening, wherein different subjects were provided with payment scales of two different lengths. Whilst the long-scale instrument included scale values up to pound 1000, the short-scale version extended only to pound 100. After controlling for inter-sample differences in, for example, income, education and health behaviour, it emerged that the long-scale instrument produced a mean willingness to pay more than 30% higher than that resulting from the short-scale version. We believe our findings to be strongly supportive of the likelihood of range bias in payment-scale instruments, with important consequences for the estimation of both average valuation and consumer surplus. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 14737755     DOI: 10.1002/hec.809

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  11 in total

1.  Willingness-to-pay and demand curves: a comparison of results obtained using different elicitation formats.

Authors:  David K Whynes; Emma J Frew; Jane L Wolstenholme
Journal:  Int J Health Care Finance Econ       Date:  2005-12

Review 2.  A 'league table' of contingent valuation results for pharmaceutical interventions: a hard pill to swallow?

Authors:  Tracey H Sach; Richard D Smith; David K Whynes
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 3.  Using the stated preference technique for eliciting valuations: the role of the payment vehicle.

Authors:  Dorte Gyrd-Hansen
Journal:  Pharmacoeconomics       Date:  2013-10       Impact factor: 4.981

4.  A Cost-Benefit Analysis of Teaching and Learning Technology in a Faculty of Pharmaceutical Sciences.

Authors:  Mark Harrison; Joshua Quisias; Emma J Frew; Simon P Albon
Journal:  Am J Pharm Educ       Date:  2019-08       Impact factor: 2.047

5.  Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility.

Authors:  Ilona M Kopits; Clara Chen; J Scott Roberts; Wendy Uhlmann; Robert C Green
Journal:  Genet Test Mol Biomarkers       Date:  2011-07-12

6.  The costs of celiac disease: a contingent valuation in Switzerland.

Authors:  Laia Soler; Nicolas Borzykowski
Journal:  Eur J Health Econ       Date:  2021-10-07

7.  Validity of Willingness to Pay Measures under Preference Uncertainty.

Authors:  Carola Braun; Katrin Rehdanz; Ulrich Schmidt
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

8.  The impact of the design of payment scales on the willingness to pay for health gains.

Authors:  Lotte Soeteman; Job van Exel; Ana Bobinac
Journal:  Eur J Health Econ       Date:  2016-09-13

9.  Longitudinal changes and determinants of parental willingness to pay for the prevention of childhood overweight and obesity.

Authors:  Romy Lauer; Meike Traub; Sylvia Hansen; Reinhold Kilian; Jürgen Michael Steinacker; Dorothea Kesztyüs
Journal:  Health Econ Rev       Date:  2020-05-28

10.  Willingness to pay for an early warning system for infectious diseases.

Authors:  Sebastian Himmler; Job van Exel; Meg Perry-Duxbury; Werner Brouwer
Journal:  Eur J Health Econ       Date:  2020-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.